Literature DB >> 24092292

Cerebellar and afferent ataxias.

Massimo Pandolfo, Mario Manto.   

Abstract

PURPOSE OF REVIEW: Ataxia is the predominant manifestation of many acquired and inherited neurologic disorders affecting the cerebellum, its connections, and the afferent proprioceptive pathways. This article reviews the phenomenology and etiologies of cerebellar and afferent ataxias and provides indications for a rational approach to diagnosis and management. RECENT
FINDINGS: The pathophysiology of ataxia is being progressively understood and linked to the functional organization of the cerebellum. The impact of cerebellar diseases on different neurologic functions has been better defined and shown not to be limited to loss of motor coordination. The role of autoimmunity is increasingly recognized as a cause of sporadic cases of ataxia. Large collaborative studies of long duration are providing crucial information on the clinical spectrum and natural history of both sporadic ataxias (such as the cerebellar form of multiple system atrophy) and inherited ataxias. New dominant and recessive ataxia genes have been identified. On the therapeutic front, progress mostly concerns the development of treatments for Friedreich ataxia.
SUMMARY: Ataxia is the clinical manifestation of a wide range of disorders. In addition to accurate clinical assessment, MRI plays a major role in the diagnostic workup, allowing us to distinguish degenerative conditions from those due to other types of structural damage to the cerebellar or proprioceptive systems. Diagnostic algorithms based on clinical features, imaging, and neurophysiologic and biochemical parameters can be used to guide genetic testing for hereditary ataxias, the diagnosis of which is likely to be greatly improved by the introduction of new-generation DNA-sequencing approaches. Some rare forms of ataxia can be treated, so their diagnosis should not be missed. Proven symptomatic treatments for ataxia are still lacking, but intensive physical therapy appears to be helpful.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24092292     DOI: 10.1212/01.CON.0000436158.39285.22

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  17 in total

1.  Can Latent Class Analysis Be Used to Improve the Diagnostic Process in Pediatric Patients with Chronic Ataxia?

Authors:  Samantha Klassen; Brenden Dufault; Michael S Salman
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

2.  Neuro-Ophthalmological Findings in Children and Adolescents with Chronic Ataxia.

Authors:  Michael S Salman; Bernard N Chodirker
Journal:  Neuroophthalmology       Date:  2015-06-17

Review 3.  Epidemiology of Cerebellar Diseases and Therapeutic Approaches.

Authors:  Michael S Salman
Journal:  Cerebellum       Date:  2018-02       Impact factor: 3.847

Review 4.  An Overview of the Current State and the Future of Ataxia Treatments.

Authors:  Kimberly Tsu Kwei; Sheng-Han Kuo
Journal:  Neurol Clin       Date:  2020-02-27       Impact factor: 3.806

5.  Differential cerebellar GABAA receptor expression in mice with mutations in CaV2.1 (P/Q-type) calcium channels.

Authors:  S Kaja; A J Payne; E Ø Nielsen; C L Thompson; A M J M van den Maagdenberg; P Koulen; T P Snutch
Journal:  Neuroscience       Date:  2015-07-21       Impact factor: 3.590

Review 6.  Role of Microglia in Ataxias.

Authors:  Austin Ferro; Carrie Sheeler; Juao-Guilherme Rosa; Marija Cvetanovic
Journal:  J Mol Biol       Date:  2019-01-18       Impact factor: 5.469

Review 7.  Recessive cerebellar and afferent ataxias - clinical challenges and future directions.

Authors:  Marie Beaudin; Mario Manto; Jeremy D Schmahmann; Massimo Pandolfo; Nicolas Dupre
Journal:  Nat Rev Neurol       Date:  2022-03-24       Impact factor: 42.937

8.  Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): Consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society.

Authors:  Jeffrey P Staab; Annegret Eckhardt-Henn; Arata Horii; Rolf Jacob; Michael Strupp; Thomas Brandt; Adolfo Bronstein
Journal:  J Vestib Res       Date:  2017       Impact factor: 2.354

9.  MME mutation in dominant spinocerebellar ataxia with neuropathy (SCA43).

Authors:  Chantal Depondt; Simona Donatello; Myriam Rai; François Charles Wang; Mario Manto; Nicolas Simonis; Massimo Pandolfo
Journal:  Neurol Genet       Date:  2016-08-18

Review 10.  Ataxia in children: early recognition and clinical evaluation.

Authors:  Piero Pavone; Andrea D Praticò; Vito Pavone; Riccardo Lubrano; Raffaele Falsaperla; Renata Rizzo; Martino Ruggieri
Journal:  Ital J Pediatr       Date:  2017-01-13       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.